Work

P-011: A randomized phase 2 study of modakafusp alfa (TAK-573) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) with a pilot diversity, equity, and inclusion (DEI) strategy

Year: 2022

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)00341-x

Authors: Jonathan Kaufman, Shebli Atrash, Don Benson, Sarah Holstein, Omar Nadeem, Noa Biran, Kaveri Suryanarayan, Yuyin Liu, LaShell Robinson, Karen Correa, Victoria Enwemadu, Xavier Parot, Dan Vogl

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4293087908

Cites:

Cited by: 2

Related to: 10